top of page
SpikImm will be attending #BIOEuropeSpring, one of the leading partnering events for the global biotechnology industry.
BIO-Europe Spring brings together key players from the life sciences ecosystem to foster collaboration, explore partnerships, and accelerate innovation in biotechnology and healthcare.
If you are attending the conference and would like to learn more about SpikImm’s technology and pipeline, we would be pleased to connect.
To arrange a meeting during the event, please contact:
SpikImm, founded by Truffle Capital develops SPK004, the most potent and long-acting anti-BK virus mAb to protect kidney transplant patients from severe complications caused by BKV (nephropathy, graft loss)
bottom of page